Literature DB >> 11360390

Effects of surgery on cognitive functioning of elderly patients with intracranial meningioma.

O Tucha1, C Smely, K W Lange.   

Abstract

Few data are available concerning the outcome of surgical removal of intracranial meningioma in elderly patients. Surgical criteria and prognostic factors are considerations in the decision as to whether neurosurgical removal should be attempted in elderly patients. The present study appears to be the first to examine the cognitive functioning of patients (n = 33) with intracranial meningiomas in the seventh and eighth decades of life prior to and following surgery. The time period between pre- and postoperative assessment was between 12 and 23 weeks. Twenty healthy subjects were also examined. For neuropsychological assessment, standardized test procedures including the examination of memory, attention, visuo-constructive abilities and executive functions were used. No significant deterioration of cognitive functioning was found following surgery. Elderly patients should not therefore be denied meningioma surgery purely on the basis of the risk of postoperative deterioration of mental functioning.

Entities:  

Mesh:

Year:  2001        PMID: 11360390     DOI: 10.1080/02688690151127608

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  16 in total

1.  Acute effects of surgery on emotion and personality of brain tumor patients: surgery impact, histological aspects, and recovery.

Authors:  Fabio Campanella; Franco Fabbro; Tamara Ius; Tim Shallice; Miran Skrap
Journal:  Neuro Oncol       Date:  2015-04-27       Impact factor: 12.300

2.  Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning.

Authors:  Sophie J M Rijnen; Ikram Meskal; Marjan Bakker; Wouter De Baene; Geert-Jan M Rutten; Karin Gehring; Margriet M Sitskoorn
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

3.  Neurocognition in individuals with incidentally-identified meningioma.

Authors:  Alissa M Butts; Stephen Weigand; Paul D Brown; Ronald C Petersen; Clifford R Jack; Mary M Machulda; Jane H Cerhan
Journal:  J Neurooncol       Date:  2017-05-25       Impact factor: 4.130

4.  Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing.

Authors:  Ikram Meskal; Karin Gehring; Sophie D van der Linden; Geert-Jan M Rutten; Margriet M Sitskoorn
Journal:  J Neurooncol       Date:  2014-12-11       Impact factor: 4.130

5.  The effects of radiotherapy on psychosocial and cognitive functioning in adults with a primary brain tumor: a prospective evaluation.

Authors:  Maria Kangas; Robyn L Tate; Janet R Williams; Robert I Smee
Journal:  Neuro Oncol       Date:  2012-10-11       Impact factor: 12.300

Review 6.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis.

Authors:  S L Bermingham
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01

7.  Surgery in elderly patients with intracranial meningioma: neuropsychological functioning during a long term follow-up.

Authors:  Andrea Di Cristofori; Barbara Zarino; Giulio Bertani; Marco Locatelli; Paolo Rampini; Giorgio Carrabba; Manuela Caroli
Journal:  J Neurooncol       Date:  2018-01-12       Impact factor: 4.130

8.  Neurocognitive functioning and health-related quality of life in patients with radiologically suspected meningiomas.

Authors:  D van Nieuwenhuizen; N Ambachtsheer; J J Heimans; J C Reijneveld; S M Peerdeman; M Klein
Journal:  J Neurooncol       Date:  2013-05-03       Impact factor: 4.130

9.  Outcome of Elderly Patients with Meningioma after Image-Guided Stereotactic Radiotherapy: A Study of 100 Cases.

Authors:  David Kaul; Volker Budach; Lukas Graaf; Johannes Gollrad; Harun Badakhshi
Journal:  Biomed Res Int       Date:  2015-05-26       Impact factor: 3.411

10.  EANO guideline on the diagnosis and management of meningiomas.

Authors:  Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.